Interv Akut Kardiol. 2010;9(1):9-11
Introduction: Catheter ablation of cavotricuspid isthmus (CTI) has become the first line therapy in patients (pts) with typical atrial flutter.
Methods: Retrospective analysis of patients (n = 61) with permanent typical atrial flutter and systolic dysfunction of left ventricle (left
ventricular ejection fraction (LVEF) ≤ 50 %). All patients underwent catheter ablation of CTI and the effect of ablation on cardiac rhythm
and LVEF after a minimum of 3 months follow-up was analysed with respect to the degree of LV systolic dysfunction and presence of
structural heart disease.
Results: Sinus rhythm (SR) was observed in 51 pts (83.6 %), with 30 only having SR (49.2 %) and 21 having SR with paroxysmal atrial
fibrillation (34.4 %). In 5 pts (8.2 %) we repeated the ablation for recurrence of typical atrial flutter. The mean LVEF after the procedure
increased from 37.8 ± 9.9 % to 43.5 ± 11.4 % (by 15 % in the whole group, p = 0.001), in subgroup with SR, the increase of LVEF was 18.8 %
(p < 0.001). In patients with nonischaemic cardiomyopathy the increase was 19.7 % (p = 0.01) compared to 12.2 % (p = 0.066) in those
with ischaemic heart disease (patients who underwent PCI or CABG).
Conclusions: Catheter ablation of CTI is an effective nonpharmacological therapy of typical atrial flutter, but a relatively large proportion
of patients develop atrial fibrillation (especially its paroxysmal form) during follow-up. The LVEF significantly improved after ablation.
A higher increase was observed in patients with severe LV systolic dysfunction. By contrast, a larger proportion of patients remained
in sinus rhythm in the subgroup with LVEF > 35 %. A more pronounced effect on systolic function of LV was observed in subjects with
nonischaemic cardiomyopathy, compared to patients with ischaemic heart disease.
Published: March 1, 2010 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...